Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization

International Immunology

Volumn 15, Issue 1, 2003, Pages 59-69

  Sewell, Diane ^a   Qing, Zhu ^a   Reinke, Emily ^a   Elliot, David ^b   Weinstock, Joel ^b   Sandor, Matyas ^a   Fabry, Zsuzsa ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Schistosoma mansoni; STAT6; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HELMINTH; HELMINTHIASIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OOCYTE; PATHOLOGY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SCHISTOSOMA MANSONI; SCORING SYSTEM; T LYMPHOCYTE; TH2 CELL; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HELMINTHS; IMMUNIZATION; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MULTIPLE SCLEROSIS; OVALBUMIN; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0037254145     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg012     Document Type: Review

References (85)

1. + T-cell memory, CD45R subsets and the persistence of antigen-a unifying concept. Immunol. Today 19:60.
2. Selin, L. K., Vergilis, K., Welsh, R. M. and Nahill, S. R. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:2489.
3. Cookson, W. O. and Moffatt, M. F. 1997. Asthma: an epidemic in the absence of infection? Science 275:41.
4. Strachan, D. P. 1989. Hay fever, hygiene, and household size. Br. Med. J. 299:1259.
5. Rook, G. A. and Stanford, J. L. 1998. Give us this day our daily germs. Immunol. Today 19:113.
6. h2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol. 22:372.
7. Shirakawa, T., Enomoto, T., Shimazu, S. and Hopkin, J. M. 1997. The inverse association between tuberculin responses and atopic disorder. Science 275:77.
8. Matricardi, P. M., Rosmini, F., Ferrigno, L., Nisini, R., Rapicetta, M., Chionne, P., Stroffolini, T., Pasquini, P. and D'Amelio, R. 1997. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. Br. Med. J. 314:999.
9. Matricardi, P. M. and Bonini, S. 2000. High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis? Clin. Exp. Allergy 30:1506.
10. Matricardi, P. M., Rosmini, F., Riondino, S., Fortini, M., Ferrigno, L., Rapicetta, M. and Bonini, S. 2000. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. Br. Med. J. 320:412.
11. Yazdanbakhsh, M., Kremsner, P. G. and van Ree, R. 2002 Allergy, parasites, and the hygiene hypothesis. Science 296:490.
12. Sewell, D. L., Reinke, E. K., Hogan, L. H., Sandor, M. and Fabry, Z. 2002. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett. 82:101.
13. Hickey, W. F., Hsu, B. L. and Kimura, H. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254.
14. H2 subsets: doubt no more. Immunol. Today 12:256.
15. Merrill, J. E. 1992. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12:167.
16. Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R. and Hofman, F. M. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice [published erratum appears in Proc. Natl Acad. Sci. USA 1992;89:10562]. Proc. Natl Acad. Sci. USA 89:574.
17. Merrill, J. E., Graves, M. C. and Mulder, D. G. 1992. Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update. Western J. Med. 156:639.
18. Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L. and Hafler, D. A. 1996. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis. Ann. NY Acad. Sci. 778:251.
19. Khoury, S. J., Hancock, W. W. and Weiner, H. L. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
20. Khoury, S. J., Gallon, L., Chen, W., Betres, K., Russell, M. E., Hancock, W. W., Carpenter, C. B., Sayegh, M. H. and Weiner, H. L. 1995. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendriticenriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med. 182:357.
21. h1 cells. J. Immunol. 155:5011.
22. Pelfrey, C. M., Rudick, R. A., Cotleur, A. C., Lee, J. C., Tary-Lehmann, M. and Lehmann, P. V. 2000. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J. Immunol. 165:1641.
23. Paul, W. E. and Seder, R. A. 1994. Lymphocyte responses and cytokines. Cell 76:241.
24. h1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 77:1120.
25. Hahn, H. J., Lucke, S., Kloting, I., Volk, H. D., Baehr, R. V. and Diamantstein, T. 1987. Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A. Eur. J. Immunol. 17:1075.
26. Olsson, T., Zhi, W. W., Hojeberg, B., Kostulas, V., Jiang, Y. P., Anderson, G., Ekre, H. P. and Link, H. 1990. Autoreactive T lymphocytes in multiple sclerosis determined by antigen- induced secretion of interferon-gamma. J. Clin. Invest. 86:981.
27. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl J. Med. 326:298.
28. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
29. Sher, A., Gazzinelli, R. T., Oswald, I. P., Clerici, M., Kullberg, M., Pearce, E. J., Berzofsky, J. A., Mosmann, T. R., James, S. L. and Morse, H. C. d. 1992. Role of T-cell derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183.
30. h2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:901.
31. h1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173:269.
32. h2 responses during infection with Schistosoma mansoni. Adv. Exp. Med. Biol. 452:67.
33. Bentwich, Z., Weisman, Z., Moroz, C., Baryehuda, S. and Kalinkovich, A. 1996. Immune dysregulation in Ethiopian immigrants in Israel-relevance to helminth infections. Clin. Exp. Immunol. 103:239.
34. h2 cytokine responses to a non-parasite antigen. J. Immunol. 148:3264.
35. h1 cytokine responses as well as delayed virus clearance. Proc. Natl Acad. Sci. USA 90:948.
36. Ledingham, D. L., McAlister, V. C., Ehigiator, H. N., Giacomantonio, C., Theal, M. and Lee, T. D. 1996. Prolongation of rat kidney allograft survival by nematodes. Transplantation 61:184.
37. Araujo, M. I., Lopes, A. A., Medeiros, M., Cruz, A. A., Sousa-Atta, L., Sole, D. and Carvalho, E. M. 2000. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch. Allergy Immunol. 123:145.
38. Lynch, N. R., Hagel, I., Perez, M., Di Prisco, M. C., Lopez, R. and Alvarez, N. 1993. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J. Allergy Clin. Immunol. 92:404.
39. Hagel, I., Lynch, N. R., DiPrisco, M. C., Lopez, R. I. and Garcia, N. M. 1993. Allergic reactivity of children of different socioeconomic levels in tropical populations. Int. Arch. Allergy Immunol. 101:209.
40. Di Prisco, M. C., Hagel, I., Lynch, N. R., Barrios, R. M., Alvarez, N. and Lopez, R. 1993. Possible relationship between allergic disease and infection by Giardia lamblia. Ann. Allergy 70:210.
41. van den Biggelaar, A. H., van Ree, R., Rodrigues, L. C., Lell, B., Deelder, A. M., Kremsner, P. G. and Yazdanbakhsh, M. 2000. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356:1723.
42. Kurtzke, J. F. 1995. MS epidemiology world wide. One view of current status. Acta Neurol. Scand. Suppl. 161:23.
43. Kurtzke, J. F. 1997. The Epidemology of Multiple Sclerosis. Chapman & Hall, London.
44. Fabry, Z., Waldschmidt, M. M., Hendrickson, D., Keiner, J., Love-Homan, L., Takei, F. and Hart, M. N. 1992. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J. Neuroimmunol. 36:1.
45. Elliott, D. E. 1996. Methods used to study immunoregulation of schistosome egg granulomas. Methods 9:255.
46. + lymphocytes by syngeneic brain microvascular smooth muscle cells. J. Immunol. 145:1099.
47. Qing, Z., Sewell, D., Sandor, M. and Fabry, Z. 2000. Antigen-specific T cell trafficking into the central nervous system. J. Neuroimmunol. 105:169.
48. Weinstock, J. V., Elliott, D., Metwali, A., Blum, A., Li, J., Qadir, K. and Sandor, M. 1999. Immunoregulation within the granulomas of murine Schistosomiasis mansoni. Microbes Infect. 1:491.
49. h1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157:4546.
50. Sacco, R. E., Jensen, R. J., Thoen, C. O., Sandor, M., Weinstock, J., Lynch, R. G. and Dailey, M. O. 1996. Cytokine secretion and adhesion molecule expression by granuloma T lymphocytes in Mycobacterium avium infection. Am. J. Pathol. 148:1935.
51. Okuda, Y., Okuda, M. and Bernard, C. C. 2002. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol. Lett. 81:25.
52. b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.
53. Chitnis, T., Najafian, N., Benou, C., Salama, A. D., Grusby, M. J., Sayegh, M. H. and Khoury, S. J. 2001. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 108:739.
54. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:162.
55. Ransohoff, R. M. 1999. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98:57.
56. Huang, D. R., Wang, J., Kivisakk, P., Rollins, B. J. and Ransohoff, R. M. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193:713.
57. Ashton-Rickardt, P. G. and Tonegawa, S. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.
58. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:1579.
59. Lehmann, P. V., Targoni, O. S. and Forsthuber, T. G. 1998. Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol. Rev. 164:53.
60. Targoni, O. S. and Lehmann, P. V. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055.
61. + T cells. J. Exp. Med. 182:1591.
62. h cell-polarizing signals. J. Immunol. 168:1704.
63. Le Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D. and Paul, W. E. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: L-2 and IL-4 are required for in vitro generation of IL-4- producing cells. J. Exp. Med. 172:921.
64. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
65. + T cells. Annu. Rev. Immunol. 12:635.
66. + T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J. Immunol. 160:5719.
67. h2 cytokine responses. Nature 362:245.
68. Falcone, M., Rajan, A. J., Bloom, B. R. and Brosnan, C. F. 1998. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol. 160:4822.
69. Shaw, M. K., Lorens, J. B., Dhawan, A., DalCanto, R., Tse, H. Y., Tran, A. B., Bonpane, C., Eswaran, S. L., Brocke, S., Sarvetnick, N., Steinman, L., Nolan, G. P. and Fathman, C. G. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711.
70. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M. 1994. Cytolkine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
71. Shaw, M. K., Kim, C., Hao, H. W., Chen, F. and Tse, H. Y. 1996. Induction of myelin basic protein-specific experimental autoimmune encephalomyelitis in C57bl/6 mice-mapping of T cell epitopes and T cell receptor V-beta gene segment usage. J. Neurosci. Res. 45:690.
72. Panitch, H. S., Hirsch, R. L., Schindler, J. and Johnson, K. P. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097.
73. Panitch, H. S. 1992. Interferons in multiple sclerosis. A review of the evidence. Drugs 44:946.
74. Knobler, R. L., Greenstein, J. I., Johnson, K. P., Lublin, F. D., Panitch, H. S., Conway, K., Grant-Gorsen, S. V., Muldoon, J., Marcus, S. G., Wallenberg, J. C. and et al. 1993. Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up. J. Interferon Res. 13:333.
75. Wildbaum, G., Youssef, S., Grabie, N. and Karin, N. 1998. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161:6368.
76. Krakowski, M. and Owens, T. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641.
77. Ferber, I. A., Brocke, S., Tayloredwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C. G. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalolmyelitis (EAE). J. Immunol. 156:5.
78. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
79. Tran, E. H., Prince, E. N. and Owens, T. 2000. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164:2759.
80. Fox, J. G., Beck, P., Dangler, C. A., Whary, M. T., Wang, T. C., Shi, H. N. and Nagler-Anderson, C. 2000. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med. 6:536.
81. Marshall, A. J., Brunet, L. R., van Gessel, Y., Alcaraz, A., Bliss, S.K., Pearce, E. J. and Denkers, E. Y. 1999. Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice. J. Immunol. 163:2089.
82. Steinman, L. 1997. Some misconceptions about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 185:2039.
83. Butterworth, A. E., Dunne, D. W., Fulford, A. J., Thorne, K. J., Gachuhi, K., Ouma, J. H. and Sturrock, R. F. 1992. Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. Immunol, Invest. 21:391.
84. Oro, A. S., Guarino, T. J., Driver, R., Steinman, L. and Umetsu, D.T. 1996. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis J. Allergy Clin. Immunol. 97:1402.
85. Tang, L., Benjaponpitak, S., DeKruyff, R. H. and Umetsu, D. T. 1998. Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production. J. Allergy Clin. Immunol. 102:428.